InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Zygmont Chester Stanley III. Officer active across 1 company, notably Revelation Biosciences, INC.. Cumulatively, 5 disclosures have been logged. Activity tracked since 11 February 2025. The latest transaction was filed on 30 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Zygmont Chester Stanley III is a declarant with 5 filings in total. The 5 sampled filings, between 2025-02-13 and 2026-05-01, concern Revelation Biosciences, INC. on XNAS, where he is Chief Financial Officer, and the modal transaction nature is Attribution. The largest amounts in the sampled filings are 428882.9197839771 EUR on 2025-10-31, 60231.04330754725 EUR on 2026-01-12, 56531.19965132163 EUR on 2025-02-13, 18292.77517360857 EUR on 2026-02-05, and 12459.17791632271 EUR on 2026-05-01.